SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) July 17, 2002
Specialty Laboratories, Inc.
(Exact name of registrant as specified in charter)
California |
001-16217 |
95-2961036 |
| (State or other jurisdiction of incorporation) |
(Commission File Number) | (IRS Employer Identification No.) |
2211 Michigan Avenue, Santa Monica, California |
90404 |
|
| (Address of principal executive offices) | (Zip Code) | |
Registrant's telephone number, including area code (310) 828-6543
(Former name or former address, if changed since last report.)
ITEM 5 OTHER EVENTS
On July 17, 2002 Specialty Laboratories, Inc., (the "Registrant") announced that the Federal Centers for Medicare & Medicaid Services (CMS) has found the Registrant to be in compliance with all condition level requirements of the federal Clinical Laboratory Improvements Act (CLIA) as of June 19, 2002. As a result, the Registrant's right to bill Medicare and Medicaid for its testing services has been reinstated as of June 19, 2002 and all actions against the Registrant's CLIA certification have been rescinded.
A copy of CMS' letter dated July 17, 2002 is filed herewith as Exhibit 99.1. A copy of the press release issued by the Registrant on July 17, 2002 concerning the foregoing matter is filed herewith as Exhibit 99.2 and is incorporated herein by reference.
ITEM 7 FINANCIAL STATEMENTS AND EXHIBITS
2
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| Specialty Laboratories, Inc. | ||||||
Date: July 18, 2002 |
By: |
/s/ FRANK J. SPINA Frank J. Spina, Chief Financial Officer |
||||
3
Exhibits The following documents are filed as exhibits to this report:
4